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High-fat meal effect on LDL, HDL, and VLDL
particle size and number in the Genetics of LipidLowering drugs and diet network (GOLDN): an
interventional study
Mary K Wojczynski1, Stephen P Glasser2, Albert Oberman2, Edmond K Kabagambe3, Paul N Hopkins4,
Michael Y Tsai5, Robert J Straka6, Jose M Ordovas7 and Donna K Arnett3*

Abstract
Background: Postprandial lipemia (PPL) is likely a risk factor for cardiovascular disease but these changes have not
been well described and characterized in a large cohort. We assessed acute changes in the size and concentration
of total and subclasses of LDL, HDL, and VLDL particles in response to a high-fat meal. Participants (n = 1048) from
the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN) Study who ingested a high-fat meal were
included in this analysis. Lipids were measured at 0 hr (fasting), 3.5 hr, and 6 hr after a standardized fat meal.
Particle size distributions were determined using nuclear magnetic resonance spectroscopy. Analyses were stratified
by baseline triglycerides (normal vs. elevated) and gender. The effect of PPL on changes in lipoprotein subclasses
was assessed using repeated measures ANOVA.
Results: Postprandially, LDL-C, HDL-C, VLDL-C, and triglycerides increased regardless of baseline triglyceride status,
with the largest increases in VLDL-C and TG; however, those with elevated triglycerides demonstrated larger
magnitude of response. Total LDL particle number decreased over the 6-hour time interval, mostly from a decrease
in the number of small LDL particles. Similarly, total VLDL particle number decreased due to reductions in medium
and small VLDL particles. Large VLDL particles and chylomicrons demonstrated the largest increase in
concentration. HDL particles demonstrated minimal overall changes in total particle number.
Conclusions: We have characterized the changes in LDL and VLDL particle number, and their subclass patterns
following a high-fat meal.
Keywords: postprandial lipemia, lipoprotein particles, NMR, high-fat meal

Background
Most studies use the measurement of fasting lipoproteins
to assess cardiovascular disease (CVD) risk [1,2]; however,
humans spend most of the day in a postprandial state.
Postprandial lipemia (PPL) is a physiological response
occurring 2 to 12 hours after consuming a meal [3]. Gross
lipid profile changes during PPL include increases in triglyceride (TG), very low-density lipoprotein cholesterol
(VLDL-C), and chylomicron concentrations; decreases in
* Correspondence: arnett@uab.edu
3
Department of Epidemiology, University of Alabama at Birmingham,
Birmingham, AL, USA
Full list of author information is available at the end of the article

high-density lipoprotein cholesterol (HDL-C) concentration; and little to no change in low-density lipoprotein
cholesterol (LDL-C) concentration. Each of these lipoprotein classes is, however, heterogeneous and composed of
various subclasses [4-6]. Lipoprotein particles are composed of different proportions of cholesterol ester (CE)
and TG, and each subclass also has specific apolipoproteins on its surface for recognition of receptors and
enzymes [7]. Constituent fractions of the lipoprotein profile can vary with respect to particle size, particle number,
and particle concentrations [8]. The ingestion of a meal
high in fat leads to distributional shifts of VLDL, LDL
(including intermediate density lipoproteins (IDL)), and
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HDL particle sizes, numbers, and plasma concentrations
[9]. The various particle sizes have also demonstrated both
pro-atherogenic (large VLDL and small LDL) and antiatherogenic (large LDL) effects [10]. Although much
research examines the major lipoproteins and lipid particle
sizes in relation to cardiovascular disease, only a few relatively small studies have used the interventional methodology described here to examine changes in lipoprotein
distribution and subclasses in the postprandial state following a high-fat challenge [11-16].
Thus, we sought to describe in a large cohort, acute
changes in lipoprotein (LDL, HDL, and VLDL) particle
sizes and numbers following a high-fat meal and to
determine if the lipoprotein particle changes would vary
by baseline triglyceride concentrations and gender.

Results
Population characteristics

Table 1 shows the characteristics of the study participants
according to gender and baseline triglyceride status. These
1048 subjects were part of a cohort of 1328 who were contacted, of whom 1123 participated (Figure 1). Of the 1048
subjects in the analysis, all were white, about half were
female, and the mean age of the study group was 48.2 (1887) years old (Table 1). The hyper-triglyceridemic individuals differed significantly from normal individuals in all
baseline traits except smoking status.
Plasma lipid concentrations

Total LDL-C levels demonstrated decreases between 0
and 6 hours following the high-fat meal (113 to 110
mg/dL in the normo-triglyceridemic men; and no
change among hyper-triglyceridemic men, p < 0.0001,
Figure 2). Among women, LDL-C levels had small but
significant (p < 0.0001) increases between 0 and 6 hours
(103 to 107 mg/dL among normo-triglyceridemic
women and 128 to 138 mg/dL among hyper-triglyceridemic women, Figure 2).
Among both normo- and hyper-triglyceridemic men,
HDL-C levels displayed a decrease at 3.5 hours but
returned to baseline levels by 6 hours, with normo-triglyceridemic men having higher HDL-C concentrations than
hyper-triglyceridemic men. Normo-triglyceridemic women
also had a decrease in HDL-C levels at 3.5 hours followed
by a return to levels slightly above baseline at 6 hours;
however, hyper-triglyceridemic women did not demonstrate a decrease at 3.5 hours and at 6 hours increased
above baseline (Figure 3). Similar to men, normo-triglyceridemic women had higher HDL-C levels than hyper-triglyceridemic women. These time and triglyceridemic
effects were significant (p < 0.0001).
All groups had a similar pattern of statistically significant
changes in VLDL-C levels in response to the high-fat
meal: large increases at 3.5 hours were followed by a
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decrease at 6 hours; however, VLDL-C levels were still elevated above baseline at 6 hours (p < 0.0001). Further, the
magnitude of the VLDL-C levels was higher among men
than women and among hyper-triglyceridemic compared
to normo-triglyceridemic individuals (Figure 4). Total triglycerides increased significantly from 83 to 145 mg/dL in
the normo-triglyceridemic men and from 188 to 307 mg/
dL in hyper-triglyceridemic men (p < 0.0001). Women displayed similar pattern of statistically significant changes (p
< 0.0001, Figure 5).
LDL particle size subclasses

Hyper-triglyceridemic participants had higher baseline
concentrations of all LDL particle subclasses compared to
normo-triglyceridemic participants (Tables 2 and 3). Additionally hyper- and normo-triglyceridemic participants
displayed similar patterns of change in LDL particle size
concentrations. In both the normo- and hyper-triglyceridemic men and women, there was a small but significant
(p < 0.0001) decrease in total LDL particle number following the high-fat meal (normo-triglyceridemic: 1212
to 1195 nmol/L in men, and 1086 to 1076 nmol/L in
women); however, the concentrations of IDL and large
LDL particles demonstrated significant increases (IDL,
normo-triglyceridemic: 28 to 43 nmol/L in men and 22 to
41 nmol/L in women, p < 0.0001; large LDL, normo-triglyceridemic: 406 to 452 nmol/L in men and 457 to 527
nmol/L in women, p < 0.0001), and the concentration of
small LDL particles demonstrated a significant decrease
(normo-triglyceridemic: 787 to 703 nmol/L in men and
611 to 518 nmol/L in women, p < 0.0001). This large
decrease in small LDL particle concentration is responsible
for the overall decrease in total LDL particle number (p <
0.0001). Despite significant (p < 0.0001) PPL changes, LDL
particle size did not demonstrate substantial changes.
HDL particle size subclasses

In response to a high-fat meal, normo- and hyper-triglyceridemic men displayed similar patterns of change in
HDL particle size concentration distributions; however,
the magnitudes of these patterns differed in hyper-compared to normo-triglyceridemic participants. In men,
there was no effect on large HDL particle concentrations, but significant increases in the concentration of
medium HDL particles (3 to 7 mmol/L in normo-triglyceridemics and 2 to 5 mmol/L in hyper-triglyceridemics,
p < 0.0001) as well as significant decreases in small
HDL particle concentrations (21 to 18 mmol/L in
normo-triglyceridemics and 24 to 21 mmol/L in hypertriglyceridemics, p < 0.0001). Furthermore, total HDL
particle number significantly increased among men in
response to the high-fat meal (p < 0.0001), which can be
attributed to the large increases in medium HDL particle size concentrations.

Men

Women

Normal Triglyceridemic (n = 317)

Hyper-Triglyceridemic (n = 185)

p-value

Normal Triglyceridemic (n = 390)

Hyper-Triglyceridemic (n = 156)

p-value

Age, y

47.6 (17.2)

Body mass index, kg/m2
Waist, cm

27.5 (4.9)
97.9 (16.1)

52.6 (14.5)

0.001

45.8 (16.4)

55.5 (14.7)

< 0.0001

30.1 (4.3)
105.3 (11.5)

< .0001
< .0001

26.9 (6.0)
89.6 (16.6)

31.2 (6.1)
102.0 (16.0)

< 0.0001
< 0.0001

Hypertension, %
Diabetes, %

22.5

36.2

0.0009

19.7

36.5

< 0.0001

4.7

10.3

0.0164

5.4

18.6

< 0.0001

12.3 (7.0)

17.5 (9.8)

< .0001

11.7 (6.5)

18.0 (9.4)

< 0.0001

101.6 (14.3)

110.6 (23.6)

< .0001

95.3 (14.3)

104.9 (18.1)

< 0.0001

6.9

8.1

0.629

7.7

5.8

0.4264

LDL-C, mg/dL

119.7 (29.3)

130.0 (29.8)

0.0002

112.8 (29.1)

137.6 (32.6)

< 0.0001

HDL-C, mg/dL
Triglycerides, mg/dL

44.5 (9.5)
92.9 (29.2)

36.2 (7.5)
244.0 (101.1)

< .0001
< .0001

54.4 (13.7)
87.9 (31.6)

46.2 (11.8)
227.9 (78.0)

< 0.0001
< 0.0001

Insulin, mU/L
Glucose, mg/dL
Current smoker, %
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Table 1 Baseline characteristics of GOLDN study population.

HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol.
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Figure 3 High-density lipoprotein cholesterol response to highfat meal, stratified by gender and baseline triglycerides.

women, medium and small HDL particle concentrations
demonstrated similar responses to the high-fat meal: medium HDL particle concentrations had significant increases
(5 to 10 mmol/L for both subgroups, p < 0.0001), and
small HDL particle concentrations had significant
decreases (20 to 13 mmol/L for normo-triglyceridemics
and 24 to 18 mmol/L for hyper-triglyceridemics, p <
0.0001). Similar to LDL size, no substantial change in
HDL size was demonstrated in response to the high-fat
meal despite its statistical significance (p < 0.0001).
Figure 1 GOLDN study recruitment.

VLDL particle size subclasses

Among both normo- and hyper-triglyceridemic individuals, women responded differently to the high-fat meal
than men. Normo-triglyceridemic women demonstrated a
significant decrease in total HDL particle number (p <
0.0001), while there was no overall change among hypertriglyceridemic women in response to the meal (33 to 32
mmol/L in normo-triglyceridemic and 35 mmol/L in
hyper-triglyceridemic). Additionally, these subgroups
demonstrated different responses for large HDL particle
concentrations where normo-triglyceridemic women displayed significant increases (8 to 9 mmol/L), and hypertriglyceridemic women displayed significant decreases in
large HDL particle concentration (6 to 5 mmol/L, p =
0.0367). For both normo- and hyper-triglyceridemic

Figure 2 Low-density lipoprotein cholesterol response to highfat meal, stratified by gender and baseline triglycerides.

Results of the PPL VLDL particle size subclass analysis
were similar in pattern for men and women, but the magnitude of change and concentration values were different,
with women, on average, having lower concentrations.
Total VLDL particle number decreased significantly
among both normo- and hyper-triglyceridemics (among
men, 48 to 42 nmol/L for normo- and 100 to 83 nmol/L
for hyper-triglyceridemics, p < 0.0001). Large VLDL particle concentrations increased significantly (1 to 3 nmol/L
among normo-triglyceridemic men and 6 to 10 nmol/L
among hyper-triglyceridemic men, p < 0.0001). Medium
and small VLDL particle concentrations demonstrated significant decreases (p < 0.0001 for both men and women).
Finally, VLDL particle size significantly increased (p <

Figure 4 Very low-density lipoprotein cholesterol response to
high-fat meal, stratified by gender and baseline triglycerides.
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Figure 5 Triglyceride response to high-fat meal, stratified by
gender and baseline triglycerides.

0.0001) among normo- and hyper-triglyceridemic men
and women.

Discussion
The present study focused on the PPL response to an
acute (1-time) high-fat meal using data derived from the
Genetics of Lipid-Lowering Drugs and Diet Network
(GOLDN) Study. We sought to describe lipoprotein particle subclass number, size, and concentrations stratified by
gender and baseline triglyceride status. Although the pattern of change observed for both men and women was
qualitatively similar, the magnitude of these changes
appeared to be more exaggerated in men compared to
women, especially for VLDL and TG response. Similar to
the response demonstrated by gender, the pattern of
change was qualitatively similar for normo- and hyper-triglyceridemic individuals; however, the magnitude was
more exaggerated among hyper-triglyceridemic than
normo-triglyceridemic individuals.
Specifically, in terms of lipoprotein particles for both
normo- or hyper-triglyceridemic individuals, we observed
little change in total particle number over the 3 time
points (up to 6 hours after the meal) for either total LDL
or HDL particle number. In contrast, for normo-triglyceridemic subjects, total VLDL particle number appeared to
rise above baseline at 3.5 hours and drop considerably
below baseline at 6 hours after the high-fat meal. This pattern was considerably different in hyper-triglyceridemic
individuals where, in both men and women, we observed a
precipitous drop relative to baseline which continued from
the 3.5 to the 6 hour time point.
Despite expected baseline differences between normoand hyper-triglyceridemic individuals, there was a reduction in small LDL particle concentrations secondary to the
PPL challenge. In normo-triglyceridemic individuals there
was a persistent decline from baseline, while in hyper-triglyceridemic men and women small LDL particle concentration appeared to plateau.
The major pattern we observed among HDL particle
subclasses was a significant shift to more medium HDL
particles and fewer small HDL particles with a non-
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significant increase in HDL-C (p > 0.05 for men and
women). Decewicz et al [9] observed decreases in medium HDL particles in a 73 case - 73 control study of a
1-year dietary lifestyle intervention; this contrasts to the
observed increase in medium HDL observed among the
546 women and 502 men studied in the GOLDN cohort
after an acute high-fat meal. It is likely that sample size
and diet (Ornish diet low in fat [9] vs high fat
(GOLDN)) are at the root of these differences in
response. In a study examining the difference in particle
distribution between diabetics and non-diabetics by Colhoun et al [10], diabetics had a lower concentration of
small HDL and a larger concentration of large HDL and
larger HDL sizes [10], a finding similar to ours; however,
the Colhoun et al study was a descriptive study of fasting particle distributions and did not include a fat-loading intervention.
In our study, the total number of VLDL particles
decreased during the postprandial period which was due
to an increase in large VLDL and chylomicrons along
with more substantial decreases in medium and small
VLDL subclasses. A decrease in medium VLDL and total
VLDL particles was also observed among the diabetic
subjects in the study by Colhoun et al [10]. Our study
contained a small proportion of diabetics, thus rendering
further stratification by diabetic status unfeasible.
Furthermore, decreases in small/medium VLDL particles
were demonstrated among women during the therapeutic
lifestyle change diet by Li et al [11]. The distributional
shift in VLDL particle subclasses was consistent and
somewhat expected since large VLDL and chylomicrons
accept triglycerides in an effort to quickly repackage and
remove them from the circulation [7]; however, the small
reduction in total VLDL particles is unexpected, especially since VLDL-C increased in response to the acute
high-fat meal.
During the PPL response to a high-fat meal, many
changes occur during lipoprotein metabolism. It has
been shown that HDL becomes enriched with TG, leading to increased removal of HDL from the plasma,
thereby decreasing HDL-C [17]. Also the transfer of cholesterol ester (CE), the main component of HDL, is
increased due to the increased activity of cholesteryl ester
transfer protein (CETP) during PPL [18], and CE is preferably transferred to chylomicrons [17], all of which are
demonstrated in our study by a postprandial decrease in
HDL-C and increase in chylomicrons. Similarly CE from
LDL is also transferred to chylomicrons during PPL [18].
Hepatic lipase (HL) activity also increases during PPL,
thus catabolizing both HDL and LDL into smaller, denser
HDL and LDL particles [17,19]; however, increases in
smaller, denser HDL and LDL were not clearly demonstrated in our population after a high-fat meal. Since it is
generally believed that smaller LDL particles are more

Normal Triglycerides
LDL particle No., nmol/L
IDL particles, nmol/L

Hyper-Triglyceridemic

p-values

0 Hr

3.5 Hr

6 Hr

0 Hr

3.5 Hr

6 Hr

Triglyceride Status

Time

1213 (22)

1187 (22)

1196 (22)

1609 (26)

1592 (26)

1601 (27)

< 0.0001

< 0.0001

Triglyceride status × time
0.5231

28 (2)

44 (3)

43 (3)

56 (3)

84 (4)

75 (3)

< 0.0001

< 0.0001

0.0002

Large LDL particles, nmol/L

406 (11)

421 (12)

452 (12)

266 (14)

308 (14)

329 (14)

< 0.0001

< 0.0001

0.0011

Small LDL particles, nmol/L

788 (21)

726 (21)

704 (22)

1268 (26)

1171 (26)

1175 (27)

< 0.0001

< 0.0001

0.0168

LDL particle size, nm

21 (0.03)

21 (0.03)

21 (0.03)

20 (0.04)

20 (0.04)

20 (0.04)

< 0.0001

< 0.0001

0.0012

HDL particle No., μmol/L

30 (0.3)

30 (0.3)

31 (0.3)

29 (0.4)

29 (0.3)

30 (0.3)

0.0034

< 0.0001

0.0157

Large HDL particles, μmol/L

5 (0.1)

5 (0.1)

5 (0.2)

3 (0.2)

3 (0.2)

3 (0.2)

< 0.0001

< 0.0001

0.0001

Medium HDL particles, μmol/L
Small HDL particles, μmol/L

3 (0.2)
21 (0.3)

5 (0.2)
19 (0.3)

7 (0.2)
18 (0.3)

2 (0.2)
24 (0.4)

4 (0.3)
22 (0.4)

5 (0.3)
21 (0.4)

< 0.0001
< 0.0001

< 0.0001
< 0.0001

0.0579
< 0.0001

HDL particle size, nm

9 (0.02)

9 (0.02)

9 (0.02)

8 (0.02)

8 (0.03)

9 (0.02)

< 0.0001

< 0.0001

< 0.0001

VLDL particle No., nmol/L

48 (2)

49 (2)

42 (2)

100 (2)

87 (2)

83 (2)

< 0.0001

< 0.0001

< 0.0001

Large VLDL particles, nmol/L

1 (0.2)

3 (0.2)

3 (0.3)

6 (0.2)

10 (0.3)

10 (0.3)

< 0.0001

< 0.0001

< 0.0001

Medium VLDL particles, nmol/L

19 (1)

28 (1)

18 (1)

55 (2)

56 (2)

48 (1)

< 0.0001

< 0.0001

< 0.0001

Small VLDL particles, nmol/L

26 (0.9)

15 (0.7)

19 (0.8)

36 (1)

18 (0.9)

24 (1)

< 0.0001

< 0.0001

< 0.0001

Chylomicrons, nmol/L

0.04 (0.01)

0.3 (0.01)

0.2 (0.02)

0.04 (0.01)

0.6 (0.02)

0.5 (0.02)

< 0.0001

< 0.0001

< 0.0001

VLDL particle size, nm

51 (0.4)

53 (0.4)

58 (0.5)

53 (0.5)

58 (0.5)

60 (0.6)

< 0.0001

< 0.0001

< 0.0001
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Table 2 Mean NMR lipoprotein particle size and number in men stratified by baseline triglyceride status.

Adjustment variables include field center, age, waist circumference, smoker, diabetes.
HDL = high-density lipoprotein; IDL = intermediate-density lipoprotein; LDL = low-density lipoprotein; NMR = nuclear magnetic resonance spectroscopy; VLDL = very low-density lipoprotein.
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Normal Triglycerides
LDL particle No., nmol/L
IDL particles, nmol/L

Hyper-Triglyceridemic

p-values

0 Hr

3.5 Hr

6 Hr

0 Hr

3.5 Hr

6 Hr

Triglyceride Status

Time

1087 (19)

1061 (18)

1077 (19)

1550 (26)

1508 (26)

1531 (26)

< 0.0001

< 0.0001

Triglyceride status × time
0.2495

22 (2)

38 (2)

41 (2)

58 (3)

70 (3)

67 (3)

< 0.0001

< 0.0001

0.0155

Large LDL particles, nmol/L

457 (13)

486 (13)

526 (13)

426 (17)

481 (17)

522 (18)

0.1334

< 0.0001

0.0029

Small LDL particles, nmol/L

614 (20)

547 (19)

521 (19)

1054 (28)

943 (27)

926 (28)

< 0.0001

< .0001

0.0076

LDL particle size, nm

21 (0.03)

21 (0.03)

21 (0.03)

21 (0.05)

21 (0.05)

21 (0.05)

< 0.0001

< 0.0001

0.007

HDL particle No., μmol/L

33 (0.3)

32 (0.3)

32 (0.3)

35 (0.4)

34 (0.4)

35 (0.4)

0.0576

< 0.0001

0.0008

Large HDL particles, μmol/L

8 (0.2)

8 (0.2)

9 (0.2)

6 (0.3)

5 (0.3)

5 (0.3)

< 0.0001

0.0581

< 0.0001

Medium HDL particles, μmol/L
Small HDL particles, μmol/L

5 (0.2)
20 (0.3)

8 (0.2)
16 (0.3)

10 (0.3)
13 (0.3)

5 (0.3)
24 (0.4)

8 (0.3)
20 (0.4)

10 (0.4)
19 (0.5)

0.7465
< 0.0001

< 0.0001
< 0.0001

0.026
0.0002

HDL particle size, nm

9 (0.02)

9 (0.02)

9 (0.02)

9 (0.03)

9 (0.03)

9 (0.03)

< 0.0001

< 0.0001

< 0.0001

VLDL particle No., nmol/L

37 (1)

40 (1)

31 (1)

84 (2)

76 (2)

75 (2)

< 0.0001

< 0.0001

< 0.0001

Large VLDL particles, nmol/L

1 (0.2)

2 (0.2)

2 (0.2)

6 (0.2)

10 (0.3)

8 (0.3)

< 0.0001

< 0.0001

< 0.0001

Medium VLDL particles, nmol/L

15 (0.9)

20 (0.9)

11 (0.9)

39 (1)

41 (1)

36 (1)

< 0.0001

< 0.0001

< 0.0001

Small VLDL particles, nmol/L

20 (0.8)

16 (0.7)

18 (0.7)

35 (1)

23 (1)

28 (1)

< 0.0001

< 0.0001

< 0.0001

Chylomicrons, nmol/L

0.04 (0.004)

0.2 (0.01)

0.2 (0.01)

0.03 (0.005)

0.4 (0.01)

0.4 (0.02)

< 0.0001

< 0.0001

< 0.0001

VLDL particle size, nm

51 (0.4)

54 (0.4)

60 (0.5)

53 (0.6)

60 (0.6)

62 (0.8)

0.0014

< 0.0001

< 0.0001
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Table 3 Mean NMR lipoprotein particle size and number in women stratified by baseline triglyceride status.

Adjustment variables include field center, age, waist circumference, smoker, diabetes.
HDL = high-density lipoprotein; IDL = intermediate-density lipoprotein; LDL = low-density lipoprotein; NMR = nuclear magnetic resonance spectroscopy; VLDL = very low-density lipoprotein.

Page 7 of 11

Wojczynski et al. Lipids in Health and Disease 2011, 10:181
http://www.lipidworld.com/content/10/1/181

atherogenic [20], further characterization and understanding of the lipoprotein fluctuations that occur due to
an acute high-fat meal may enhance our understanding
of the relationship of lipoprotein particle subclasses to
the increased risk for CVD.
This study differs from the majority of previous studies
examining dietary influences on PPL that were conducted
in smaller study populations, utilized different dietary
interventions, and did not report changes in LDL particle
subclasses [11,12]. For example, Li et al [11] studied 33
subjects and showed that therapeutic lifestyle changes
focused on diet decreased IDL among men, but not
women. This is opposite to what we observed, and this is
likely due to differences in the dietary intervention of Li
et al [11] who utilized a diet low in total fat, saturated fat,
and cholesterol, compared to the GOLDN intervention
which was high in total fat and cholesterol. Additionally,
random variation could explain differences since the Li
et al [11] study evaluated 33 subjects compared to the
1048 reported from GOLDN.
The strengths of this study are its large sample size,
the use of a standardized acute fat load, and the use of
NMR technology to characterize particle size subclasses.
To our knowledge, it is the largest PPL study conducted
to date. Our study did not measure serum apolipoprotein B and is not a CVD outcome or mechanistic study;
therefore, we do not know for certain how or why these
lipoprotein particle distributional shifts occur or how
they might impact CVD risk. Nonetheless, among
hyper-triglyceridemic individuals, the prolonged return
to baseline levels may add to an already elevated atherogenic profile [18].
Additionally, we did not obtain information on the
activity level of enzymes and proteins that are known to
be activated during the PPL response, such as CETP and
HL [18]. Specific knowledge of how these enzymes and
proteins respond during an acute high-fat meal challenge
would greatly enhance the understanding of our findings
as well as further the understanding of lipoprotein metabolism. We only examined the acute response to 1 highfat meal, but since humans are in a non-fasting postprandial state for a majority of the day [21], the changes that
we demonstrated may actually never return to baseline
except during the latter phases of sleep. Thus, it may be
the length of time that these changes in lipoprotein particle fluctuations exist that is important in atherogenesis.
Another possible mechanism for atherogenesis of the
particle subclasses is the fluctuations in the TG:CE content of the particles [18]. Since each lipoprotein particle
subclass is composed of varying proportions of TG and
CE, it may be that the changes in those proportions are
atherogenic. Lastly, these findings may not extend to
other racial groups, as our study population was all white.
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Conclusions
Postprandial lipemia persists for at least 6 hours following a high-fat meal. We confirmed that men differ from
women in the PPL response, and that the PPL response
varies based on baseline triglyceride profile. We demonstrated an increase in IDL particles, especially in normotriglyceridemic women, and an increase in triglycerides
in both men and women. Large HDL also changed in
hyper-triglyceridemic women (17% decrease was
observed), which is interesting in view of the clinically
observed greater risk of CVD in hyper-triglyceridemic
women compared to men [22]. Overall, VLDL particles
decreased but triglyceride-rich large VLDL and chylomicrons (with their propensity to generate atherogenic remnants) increased dramatically; however, the actual
magnitude of change in total VLDL particles was relatively small. As our results demonstrate, the lipoprotein
fluctuations are distinct, and some are not intuitive based
on our existing knowledge of lipids and lipoprotein metabolism. Finally, our findings provide further mechanistic
insight into the changes in lipoprotein metabolism occurring after an acute high-fat meal.
Methods
Study population

The Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN) study population consisted of 189
families who were recruited from 3-generational pedigrees from the NHLBI Family Heart Study Minneapolis,
MN, and Salt Lake City, UT, field centers. The overarching intent of GOLDN was to identify loci contributing to phenotypic variation in response to a high-fat
meal and fenofibrate therapy. The Institutional Review
Boards at the University of Alabama, the University of
Minnesota, the University of Utah, and Tufts University
approved the study protocol.
Inclusion and exclusion criteria

Participants had to meet the following criteria: White
(other racial groups were excluded by design since the
recruitment sources were extant cohorts of white families
from Utah and Minnesota), male or female, ≥ 18 years of
age, fasting triglycerides (TGs) < 1500 mg/dL, willingness
to participate in the study and attend the scheduled clinic
exams, part of a family with at least 2 members in a sibship, AST and ALT tests within normal range, and creatinine ≤ 2.0. Exclusion criteria for the fenofibrate
intervention included the following: history of liver, kidney, pancreas, or gall bladder disease or malabsorption;
pregnancy or women of childbearing potential not using
an acceptable form of contraception; insulin use; known
hypersensitivity to fenofibrate; pancreatitis within 12
months prior to enrollment; and current use of warfarin
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and/or nutraceuticals. Subjects using hypolipidemic
drugs were asked to consult with their physicians to
determine whether they could be taken off medications
for 4 weeks prior to and for the duration of the study;
informed consent for drug withdrawal was obtained.
Only subjects who remained untreated with any prescription or over-the-counter hypolipidemic medication were
eligible.
Study design

Participants underwent 2 interventions: an acute fat loading dietary challenge and a short-term (3 weeks) openlabel intervention trial of fenofibrate. The specific methodology of GOLDN is reported elsewhere [23,24]. For this
analysis, we report LDL, HDL, and VLDL particle subclass concentrations, size and number in response to an
acute standardized high fat challenge.
The high-fat challenge followed the protocol of Patsch
et al [25]. The caloric intake of the intervention meal was
determined by body surface area, containing 700 kilocalories per m2 of body surface area (2.93 MJ/m2 body surface area). The meal composition was 83% of calories
from fat, 14% from carbohydrates, and 3% from protein.
The meal was formulated to have a cholesterol content
of 240 mg and a polyunsaturated:saturated fat ratio of
0.06. Based on these guidelines, the average individual
ingested 175 mL of heavy whipping cream (39.5% fat)
combined with 7.5 mL powdered, instant, non-fat, dry
milk, and blended with ice. To increase palatability of the
drink, 15 mL of chocolate- or strawberry-flavored syrup
was also added. Participants had 15 minutes to ingest
this meal and were required to fast a minimum of 8
hours prior to the meal. Immediately before ingestion, we
drew blood samples on all participants (0 hr, fasting), and
then again at 3.5 and 6 hours after the high-fat meal.
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Lipoprotein subclass analysis

Proton nuclear magnetic resonance (NMR) spectroscopy
was used to determine LDL, HDL, and VLDL particle size
subclass concentrations (Liposcience, Raleigh, NC). Measured amplitudes after exposure to a 400 MHz magnet
and known distinct lipid methyl group NMR spectroscopic
profiles were used to determine the subclass concentrations [8,26-30]. Concentrations of LDL and VLDL subclasses are reported as nanomoles per liter and HDL is
reported as mmol/L. The different lipoprotein particles
correspond to the following average size in nanometers
(nm): intermediate density lipoprotein (IDL), 23-27 nm;
large LDL, 21.2-23 nm; small LDL, 18-21.2 nm; large
HDL, 8.8-13 nm; medium HDL, 8.2-8.8 nm; small HDL,
7.3-8.2 nm; large VLDL, 60-200 nm; medium VLDL, 3560 nm; and small VLDL, 27-35 nm [8,11,31]; relative size
is depicted in Figure 6.
Statistical methods

All analyses were conducted separately for men and
women and stratified by baseline hyper-versus normo-triglyceride levels (TG > 150 vs TG ≤ 150) due to significant
interactions between gender and baseline triglyceride
concentrations in analyses for LDL, HDL, and VLDL. To
determine the significance of differences in percentages
between male and female normo- and hyper-triglyceridemic individuals, we used the Pearson c 2 and Fisher

Biochemical assays

Serum and EDTA-anticoagulant tubes were collected and
processed using a standardized protocol, aliquoted, and
stored at -70°C until time of use. Analysis was completed
on all stored samples at the end of the study and all samples for an individual were processed in the same batch to
reduce measurement error. Triglyceride measurements
were calculated using the glycerol-blanked enzymatic
method on the Roche COBAS FARA centrifugal analyzer
(Roche Diagnostics Corporation). Hyper-triglyceridemia
was defined as a baseline triglyceride ≥ 150 mg/dL. HDLC was calculated using the same procedure as TG measurement after precipitation of non-HDL cholesterol with
magnesium/dextran. LDL-C measurement employed a
homogeneous direct method (LDL Direct Liquid Select™
Cholesterol Reagent; Equal Diagnostics) on a Hitachi 911
Automatic Analyzer.

Figure 6 Nuclear magnetic resonance-derived low-density
lipoprotein (LDL), high-density lipoprotein (HDL), and very
low-density lipoprotein (VLDL) particle size subclasses.
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exact tests. To compare crude means, we used ANOVA
and Student’s t-test. Results are expressed as least
squares mean (standard error). We examined changes in
subclass particle size concentrations that occurred during
the dietary fat challenge (baseline, 3.5 hours, and 6
hours) using repeated-measures ANOVA in which the
family was modeled as a random variable. All statistical
calculations were performed using SAS 9.1 (SAS Institute, Inc.).
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